CSBR
Champions Oncology, Inc.
$4.79-0.02 (-0.42%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖AI Insight
Latest Insider Transactions
9 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-10-16 | 2026-10-15 | Ackerman Joel | Director | Exercise Conversion | 69,794 | $1.60 | $111,670 | N/A | N/A |
| 2026-10-16 | 2026-10-15 | Ackerman Joel | Director | Exercise Conversion | 69,794 | $1.60 | $111,670 | N/A | N/A |
| 2025-11-07 | 2025-11-05 | Ackerman Joel | Director | Award | 21,216 | $6.80 | $144,269 | N/A | N/A |
| 2025-11-07 | 2025-11-05 | Mendelson Daniel Newman | Director | Award | 13,790 | $6.80 | $93,772 | N/A | N/A |
| 2025-11-07 | 2025-11-05 | Sidransky David | Director | Award | 21,216 | $6.80 | $144,269 | N/A | N/A |
| 2025-11-07 | 2025-11-05 | Tobin Scott R | Director | Award | 25,460 | $6.80 | $173,128 | N/A | N/A |
| 2025-11-07 | 2025-11-05 | Breitfeld Philip P. | Director | Award | 13,790 | $6.80 | $93,772 | N/A | N/A |
| 2025-11-06 | 2025-10-30 | Ackerman Joel | Director | Exercise Conversion | 94,405 | $2.10 | $198,251 | N/A | N/A |
| 2025-11-06 | 2025-10-30 | Ackerman Joel | Director | Exercise Conversion | 94,405 | $2.10 | -$198,251 | N/A | N/A |
CSBR
Director
Exercise Conversion
$111.7K
Ackerman Joel69,794 shares @ $1.60
Filed 2026-10-16Trade 2026-10-15
CSBR
Director
Exercise Conversion
$111.7K
Ackerman Joel69,794 shares @ $1.60
Filed 2026-10-16Trade 2026-10-15
CSBR
Director
Exercise Conversion
$198.3K
Ackerman Joel94,405 shares @ $2.10
Filed 2025-11-06Trade 2025-10-30
CSBR
Director
Exercise Conversion
-$198.3K
Ackerman Joel94,405 shares @ $2.10
Filed 2025-11-06Trade 2025-10-30